Headline News about Travere Therapeutics, Inc. - Common Stock![]()
The Latest Analyst Ratings for Travere Therapeutics
August 18, 2023
Via Benzinga
![]() ![]() ![]() ![]() Via Benzinga
![]()
Expert Ratings for Travere Therapeutics
July 18, 2023
Via Benzinga
![]()
Analyst Ratings for Travere Therapeutics
June 07, 2023
Via Benzinga
![]() Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() ![]() ![]()
Recap: Travere Therapeutics Q1 Earnings
May 04, 2023
Via Benzinga
![]()
Earnings Outlook For Travere Therapeutics
May 03, 2023
Via Benzinga
![]()
The Latest Analyst Ratings for Travere Therapeutics
April 17, 2023
Via Benzinga
![]() ![]() Via Benzinga
![]() Via Benzinga
![]() ![]()
Travere Therapeutics's Return On Capital Employed Overview
February 28, 2023
Via Benzinga
![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|